Trupanion (NASDAQ:TRUP) COO Sells $140,105.16 in Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) COO John Gallagher sold 5,283 shares of Trupanion stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $26.52, for a total value of $140,105.16. Following the sale, the chief operating officer directly owned 32,387 shares of the company’s stock, valued at approximately $858,903.24. The trade was a 14.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Trupanion Stock Performance

Shares of NASDAQ TRUP opened at $28.77 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.69 and a quick ratio of 1.69. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 63.93 and a beta of 1.62. The stock’s fifty day moving average price is $32.15 and its two-hundred day moving average price is $38.07. Trupanion, Inc. has a one year low of $25.24 and a one year high of $57.88.

Trupanion (NASDAQ:TRUPGet Free Report) last released its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The business had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million. During the same quarter last year, the company posted $0.04 earnings per share. The company’s revenue was up 11.7% on a year-over-year basis. On average, equities analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on TRUP shares. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Wall Street Zen downgraded Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Stifel Nicolaus reduced their price objective on shares of Trupanion from $38.00 to $35.00 and set a “hold” rating on the stock in a research note on Friday, February 13th. Weiss Ratings lowered shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Finally, Cantor Fitzgerald cut their price target on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a report on Wednesday, January 14th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $45.50.

View Our Latest Stock Analysis on TRUP

Institutional Investors Weigh In On Trupanion

A number of hedge funds have recently made changes to their positions in the stock. Federated Hermes Inc. acquired a new position in Trupanion during the 3rd quarter worth approximately $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Trupanion during the third quarter worth $39,000. Nisa Investment Advisors LLC increased its holdings in shares of Trupanion by 44.1% during the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock worth $54,000 after buying an additional 300 shares in the last quarter. Kelleher Financial Advisors bought a new position in shares of Trupanion in the 3rd quarter valued at $74,000. Finally, Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion during the 4th quarter valued at $64,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Further Reading

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.